Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.
Latest website image capture
Clouds background image

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page

  1. Check
    today
    Change Detected
    Summary
    A new revision label 'Revision: v3.5.4' was added to the study record history, replacing the previous 'Revision: v3.5.3'.
    Difference
    0.1%
    Check dated 2026-05-16T10:24:36.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A minor interface/version update is reflected by changing the displayed “Revision” from v3.5.2 to v3.5.3, without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-25T05:21:37.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-18T00:20:43.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A new revision (v3.5.0) was added to the record history and an older revision (v3.4.3) was removed.
    Difference
    0.1%
    Check dated 2026-03-20T03:28:15.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the record history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T21:26:27.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    A new version entry v3.4.2 was added to the record history, and the previous entry v3.4.1 was removed.
    Difference
    0.1%
    Check dated 2026-02-12T01:40:12.000Z thumbnail image

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.